Jump to main content
Jump to site search

Issue 31, 2018
Previous Article Next Article

Phenanthriplatin(IV) conjugated multifunctional up-converting nanoparticles for drug delivery and biomedical imaging

Author affiliations

Abstract

Platinum-based drugs cisplatin, carboplatin, and oxaliplatin are widely used in the clinical treatment of cancer. However, the clinical applications of platinum-based drugs are greatly limited by the side-effects, lack of selectivity, fast blood clearance, and intrinsic or acquired drug resistance. In this study, we report an anticancer drug delivery system based on phenanthriplatin(IV) (Phen-Pt(IV))-conjugated NaGdF4:Yb3+/Er3+ nanoparticles. The upconversion luminescent NaGdF4:Yb3+/Er3+ nanoparticles (UCNPs) were further modified with polyethyleneimine (PEI), poly(ethylene glycol) (PEG) and the cancer targeting ligand arginine–glycine–aspartic peptide (RGD), resulting in the formation of water-dispersible and biologically functionalized UCNP@PEI–Phen-Pt–PEG–RGD nanoparticles. The Phen-Pt-conjugated UCNP@PEI–Phen-Pt–PEG–RGD nanoparticles exhibited an obvious cytotoxic effect on Hep-2 cells (Human Laryngeal Carcinoma cell line) via MTT assay. Meanwhile, the endocytosis process of Phen-Pt-conjugated NaGdF4:Yb3+/Er3+ nanoparticles by Hep-2 cells was demonstrated through flow cytometry and ICP-MS. In addition, the upconversion luminescence image of UCNP@PEI–Phen-Pt–PEG–RGD taken up by cells shows green emission under 980 nm infrared laser excitation, making the UCNP@PEI–Phen-Pt–PEG–RGD nanocomposites promising candidates as bioimaging agents. Moreover, these UCNPs were further explored for in vitro and in vivo T1-weighted magnetic resonance (MR) imaging. The in vivo experiments on mice also confirmed that the Phen-Pt(IV)-conjugated nanoparticles have a relatively high tumor inhibition rate. These results indicate that the multifunctional nanoparticles can be expected to be a platform for simultaneous imaging and cancer therapeutic applications.

Graphical abstract: Phenanthriplatin(iv) conjugated multifunctional up-converting nanoparticles for drug delivery and biomedical imaging

Back to tab navigation

Supplementary files

Publication details

The article was received on 20 Apr 2018, accepted on 11 Jul 2018 and first published on 13 Jul 2018


Article type: Paper
DOI: 10.1039/C8TB01034J
Citation: J. Mater. Chem. B, 2018,6, 5059-5068
  •   Request permissions

    Phenanthriplatin(IV) conjugated multifunctional up-converting nanoparticles for drug delivery and biomedical imaging

    B. Teng, Y. Han, X. Zhang, H. Xiao, C. Yu, H. Li, Z. Cheng, D. Jin, K. Wong, P. Ma and J. Lin, J. Mater. Chem. B, 2018, 6, 5059
    DOI: 10.1039/C8TB01034J

Search articles by author

Spotlight

Advertisements